Integrated Sensing Systems, Inc. (ISSYS) and the University of Michigan announced that they have received a $1.5 million National Institute of Health (NIH) grant titled "Novel Micro-Implant To Measure Intracardiac Pressure In Congenital Heart Patients." Dr. Martin Bocks, a pediatric cardiologist at the University of Michigan and the project's medical principal investigator, stated that "we are extremely excited to continue working with ISSYS to develop a wireless, implantable pressure sensor for our patients with complex forms of congenital heart disease. This pressure sensing implant has the potential to greatly improve the care we provide to our most complex patients and will provide us with unprecedented opportunities to learn more about their unique physiology."
Dr. Nader Najafi, ISSYS President and CEO and the project's technical principal investigator, stated that, "this grant aids us to develop wireless, batteryless, intelligent, miniature implants for patients with congenital and structural heart diseases. In particular, this grant paves the way for the start of clinical studies in infants and children with complex congenital heart defects. The pediatric medical device field represents unique commercialization challenges due to its small size and stringent requirements. We are grateful to NIH and the National Heart Lung and Blood Institute (NHLBI) for this needed support for the challenging pediatric device field. The University of Michigan is an ideal partner for us to develop this unique pediatric implant. The results of this effort will have important spillover effects for broader applications within the field of adult and pediatric cardiovascular medicine."
ISSYS is a developed of MEMS technologies for industrial and medical devices, microfluidic and scientific analytical sensing applications. Founded in 1995, ISSYS is one of the oldest independent MEMS companies in the US. ISSYS operates a MEMS fabrication facility located near Ann Arbor, Michigan.